Aims Diabetes mellitus is associated with metabolic bone disease and increased low-impact fractures. The insulin-sensitizer metformin possesses in vitro, in vivo and ex vivo osteogenic effects, although this has not been adequately studied in the context of diabetes. We evaluated the effect of insulin-deficient diabetes and/or metformin on bone microarchitecture, on osteogenic potential of bone marrow progenitor cells (BMPC) and possible mechanisms involved. Methods Partially insulin-deficient diabetes was induced in rats by nicotinamide/streptozotocin-injection, with or without oral metformin treatment. Femoral metaphysis micro-architecture, ex vivo osteogenic potential of BMPC, and BMPC expression of Runx-2, PPARγ and receptor for advance...
Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, ...
Diabetes and periodontitis are comorbidities and may share common pathways. Several reports indicate...
Diabetes and periodontitis are comorbidities and may share common pathways. Several reports indicate...
Aims: Diabetes mellitus is associated with metabolic bone disease and increased lowimpact fractures....
Aims: Diabetes mellitus is associated with metabolic bone disease and increased lowimpact fractures....
Diabetes mellitus is associated with bone loss. Patients with type 2 diabetes are frequently treated...
Diabetes mellitus is associated with bone loss. Patients with type 2 diabetes are frequently treated...
Diabetes mellitus is associated with bone loss. Patients with type 2 diabetes are frequently treated...
Long-term treatment with the insulin-sensitizer rosiglitazone reduces bone mass and increases fractu...
Aims Deleterious effects of metabolic syndrome (MS) on bone are still controversial. In this study w...
Aims: Deleterious effects of metabolic syndrome (MS) on bone are still controversial. In this study ...
This study evaluated the influence of type 2 diabetes mellitus on bone loss, bone repair and cytokin...
Patients with long-term type 1 and type 2 diabetes or “diabetic osteopathy”. These include osteopeni...
Aims: Deleterious effects of metabolic syndrome (MS) on bone are still controversial. In this study ...
Long-term treatment with the insulin-sensitizer rosiglitazone reduces bone mass and increases fractu...
Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, ...
Diabetes and periodontitis are comorbidities and may share common pathways. Several reports indicate...
Diabetes and periodontitis are comorbidities and may share common pathways. Several reports indicate...
Aims: Diabetes mellitus is associated with metabolic bone disease and increased lowimpact fractures....
Aims: Diabetes mellitus is associated with metabolic bone disease and increased lowimpact fractures....
Diabetes mellitus is associated with bone loss. Patients with type 2 diabetes are frequently treated...
Diabetes mellitus is associated with bone loss. Patients with type 2 diabetes are frequently treated...
Diabetes mellitus is associated with bone loss. Patients with type 2 diabetes are frequently treated...
Long-term treatment with the insulin-sensitizer rosiglitazone reduces bone mass and increases fractu...
Aims Deleterious effects of metabolic syndrome (MS) on bone are still controversial. In this study w...
Aims: Deleterious effects of metabolic syndrome (MS) on bone are still controversial. In this study ...
This study evaluated the influence of type 2 diabetes mellitus on bone loss, bone repair and cytokin...
Patients with long-term type 1 and type 2 diabetes or “diabetic osteopathy”. These include osteopeni...
Aims: Deleterious effects of metabolic syndrome (MS) on bone are still controversial. In this study ...
Long-term treatment with the insulin-sensitizer rosiglitazone reduces bone mass and increases fractu...
Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, ...
Diabetes and periodontitis are comorbidities and may share common pathways. Several reports indicate...
Diabetes and periodontitis are comorbidities and may share common pathways. Several reports indicate...